Download full report with analyst certification and important disclosures
Nov 13 2017, 08:40 GMT
Amryt has signed an exclusive distribution agreement with El Seif, a Saudi Arabian distributor of medical devices and pharmaceuticals. The agreement covers its commercial product Lojuxta and its late stage clinical drug AP101. This is an important milestone for Amryt as it establishes a presence in the key commercial territory of Saudi Arabia and is indicative of the company’s broader strategy to extend its footprint across key territories.